Target Audience

This activity is intended for physicians, physician assistants, pharmacists, nurses, psychologists, social workers and certified health education specialists providing sexual and reproductive healthcare services.

Educational Objectives

After completing this activity, the participant should be better able to:
• Describe how to access and clinically apply the US Medical Eligibility for Contraceptive Use guideline and it’s app.
• Demonstrate patient centered language for describing an intervention to a patient for those experiencing unacceptable bleeding.
• Discuss 2 management options for clients using contraception who experience unacceptable bleeding.
• List 2 advantages and 2 disadvantages of contraceptive methods that were FDA approved recently as compared to older contraceptive methods.
• Explain how to address contraception needs and preferences for clients with chronic medical conditions; lupus, obesity, bleeding disorders, and cardiac conditions.
• Apply current best practices for identifying and managing diseases affecting sexual or reproductive health.
• Demonstrate person-centered language for meeting individuals’ family planning needs.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned
and implemented by the Postgraduate Institute for Medicine and
American Sexual Health Association. Postgraduate Institute for
Medicine is jointly accredited by the Accreditation Council for
Continuing Medical Education (ACCME), the Accreditation Council
for Pharmacy Education (ACPE), and the American Nurses Credentialing Center
(ANCC), to provide continuing education for the healthcare team.

Credit Designation

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this live activity for a maximum of 16 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 16 contact hours. (If applicable, for APRNs, live activity). Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined.

Continuing Physician Assistant Education

Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 16 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

CHES -Certified Health Education Specialist

Sponsored by Postgraduate Institute for Medicine, a designated provider of continuing
education contact hours (CECH) in health education by the National Commission for
Health Education Credentialing, Inc. This program is designated for Certified Health
Education Specialists (CHES) and/or Master Certified Health Education Specialists
(MCHES) to receive up to 16 total entry-level Category I contact education contact

Faculty List

Click here for a complete faculty list.

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

All remaining faculty/planning committee members have nothing to disclose.

Planners and Managers

The PIM planners and managers have nothing to disclose. The American Sexual Health
Association planners and managers have nothing to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.  The planners of this activity do not recommend the use of any agent outside of the labeled indications.  The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development.  The information presented in this activity is not meant to serve as a guideline for patient management.  Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.